In this issue:
FMT decreases mortality in critically ill patients with severe/fulminant C. difficile infection
Potential of cannabinoid-1 inverse agonists in IBS with constipation
LBT to predict response to rifaximin in IBS with diarrhoea
Clinical characteristics of COVID-19 patients with digestive symptoms
Digestive symptoms in COVID-19 patients with mild disease severity
COVID-19 outcomes in Italian IBD patients
Dupilumab for active eosinophilic oesophagitis
Allogenic FMT vs. autologous transplantation in IBS
Please login below to download this issue (PDF)